Humedix wins $20 Million Export Tower Award for globally expanding Korea’s aesthetic Industry with Elravie < Device/ICT < Article

Humedix, an aesthetic subsidiary of Huons Group, said on Friday it won the “$20 Million Export Tower Award” for contributing to the globalization of Korea’s aesthetic industry through its hyaluronic acid filler (HA), Elravie. 

The annual Trade Day Awards, organized by the Korea International Trade Association (KITA) and the Ministry of Trade, Industry and Energy, recognize companies that successfully make inroads into foreign markets and contribute to the nation’s export growth.

Kang Min-jong, senior managing director at Humedix, poses for a photo, celebrating Humedix’ winning of the $20 Million Export Tower Award.  (Courtesy of Humedix)

Since establishing an international division in 2021, Humedix has expanded its exports to 19 countries, including China and Brazil, and generated approximately $24 million in export revenue over the past year, according to the company.

In addition to the Export Tower Award, Humedix received the Minister of Trade, Industry and Energy Award, solidifying its position as a key player in global exports and market expansion. 

CEO Kim Jin-hwan said, “We are focused on targeting global markets with high-value aesthetic products beyond fillers. With plans to enter the U.S. and Europe, we aim to establish Humedix as a global leader in the aesthetic industry.”

Humedix is renowned for its innovative high-purity HA production technology and its signature filler, Elravie. The company also applies its HA expertise to other medical fields, including arthritis treatments, OTC products, and ophthalmic solutions.

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}